Federal Register / Vol. 60, No. 243 / Tuesday, December 19, 1995 / Notices 65351

records on committee participation and

status of medical device standards used

by the Center.

3. Prior Delegations of Authority.

Pending further delegations, directives,

or orders by the Commissioner of Food

and Drugs, all delegations of authority

to positions of the affected organizations

in effect prior to this date shall continue

in effect in them or their successors.

Dated: November 28, 1995.

David A. Kessler,

Commissioner of Food and Drugs.

[FR Doc. 95–30813 Filed 12–18–95; 8:45 am]

BILLING CODE 4160–01–F

Food and Drug Administration

Statement of Organization, Functions,

and Delegations of Authority

Part H, Chapter HF (Food and Drug

Administration) of the Statement of

Organization, Functions, and

Delegations of Authority for the

Department of Health and Human

Services (35 FR 3685, February 25,

1970, and 56 FR 29484, June 27, 1991,

as amended most recently in pertinent

part at 60 FR 53382, October 13, 1995)

is amended to reflect the change in title

of the International Affairs Staff to the

Office of International Affairs, Office of

External Affairs (OEA), in the Food and

Drug Administration (FDA).

The Office of International Affairs

will continue to serve as the Agency

focal point for developing and

maintaining international

communications and programs. FDA

believes that the increase in

international activity with regard to

FDA regulated products and activities

necessitates the elevation of the

International Affairs Staff to office level

status within OEA and that this action

further enhances the management and

coordination of Agency international

activities.

Under section HF-B, Organization:

1. Delete the subparagraph,

International Affairs Staff (HFAQA),

under the Office of External Affairs

(HFAQ), in its entirety and insert a new

subparagraph, Office of International

Affairs (HFAQA), under the Office of

External Affairs (HFAQ), reading as

follows:

Office of International Affairs

(HFAQA). Serves as the Agency focal

point for developing and maintaining

international communications and

programs.

Establishes and provides an Agency

liaison on international activities with

the Department, Public Health Service

(PHS), and other Federal agencies,

foreign governments, including foreign

embassies, and international

organizations.

Represents the Agency at meetings,

conferences, and symposia relating to

international obligations; briefs Agency

participants in such international

activities.

Establishes, identifies, interprets, and

clarifies, in cooperation with

appropriate Agency components, the

Agency’s international obligations and

needs, including those associated with

bilateral programs which involve extra

budgetary support.

Establishes and maintains an

international information exchange

program concerning Agency policies

and programs to provide interchange

between FDA and counterpart agencies

in foreign countries and international

organizations.

Assists in the development,

negotiation, and monitoring of

agreements with foreign governments

and international organizations in

cooperation with appropriate Agency

components; and acts as the Agency

focal point for intergovernmental

conferences.

Negotiates the preparation and

implementation of technical assistance

programs (including formal training

programs and surveys) with foreign

governments and international

organizations in areas relating to the

Agency mission. Coordinates ongoing

technical assistance operations with

appropriate components within the

Department, PHS, and the Agency.

Directs the Agency’s International

Visitors Program, providing participants

with policy briefings, technical training,

and/or assistance in response to specific

needs

2. Prior Delegations of Authority.

Pending further delegations, directives,

or orders by the Commissioner of Food

and Drugs, all delegations of authority

to positions of the affected organizations

in effect prior to this date shall continue

in effect in them or their successors.

Dated: December 5, 1995.

David A. Kessler,

Commissioner of Food and Drugs.

[FR Doc. 95–30744 Filed 12–18–95; 8:45 am]

BILLING CODE 4160–01–F

Health Resources and Services

Administration

Advisory Council; Notice of Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), announcement is

made of the following National

Advisory body scheduled to meet

during the month of January 1996.

Name: Council on Graduate Medical

Education

Date and Time: January 9, 1996, 1:00 p.m.–

5:00 p.m., January 10, 1996, 8:30 a.m.–4:00

p.m.

Place: Governor’s House Hotel, 17th Street

at Rhode Island Avenue, N.W., Washington,

D.C. 20036

The meeting is open to the public.

Purpose: Provides advice and

recommendations to the Secretary and to the

Committees on Labor and Human Resources,

and Finance of the Senate and the

Committees on Energy and Commerce and

Ways and Means of the House of

Representatives, with respect to (A) the

supply and distribution of physicians in the

United States; (B) current and future

shortages of physicians in medical and

surgical specialties and subspecialties; (C)

issues relating to international medical

graduates; (D) appropriate Federal policies

regarding (A), (B), and (C) above; (E)

appropriate efforts to be carried out by

medical and osteopathic schools, public and

private hospitals and accrediting bodies

regarding matters in (A), (B), and (C) above;

(F) deficiencies in the needs for

improvements in, existing data bases

concerning supply and distribution of, and

training programs for physicians in the

United States.

Agenda: The Agenda will include a panel

to discuss International Medical Graduates,

entry and participation in the U.S. physician

workforce. A panel to discuss Legislation and

GME Reform, House Ways and Means

Committee. Report on transition funding

issues; Report and updates on the work

groups, Minorities in Medicine; Geographic

Distribution/Medical Education Consortia;

Physician Competencies in a Managed Care

World; and IMG Entry and Participation in

the Physician Workforce.

Anyone requiring information

regarding the meeting should contact F.

Lawrence Clare, M.D., M.P.H., Deputy

Executive Secretary, Telephone 301–

443–6326, Council on Graduate Medical

Education, Division of Medicine,

Bureau of Health Professions, Room 9A–

27, Parklawn Building, 5600 Fishers

Lane, Rockville, MD 20857.

Agenda items are subject to change as

priorities dictate.

Dated: December 12, 1996.

Jackie E. Baum,

Advisory Committee Management Officer.

[FR Doc. 95–30816 Filed 12–18–95; 8:45 am]

BILLING CODE 4160–15–P

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following meeting